Nadir Buyuktimkin

This inventor holds 20 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Topical Formulations. Top assignees: Nexmed (Holdings) Incorporated, Nuvo Research Inc., Achelios Therapeutics, Inc.. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadir Buyuktimkin. Retrieved from https://idiyas.com/inventor/nadir-buyuktimkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 10)

% Patents Active = 80.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 273(Granted Patents)

Location History:

Lawrence, KS (US) (2000 - 2004)
San Diego, CA (US) (2013 - 2022)

Company Filing History:

6 out of 29

Nexmed (Holdings) Incorporated

Achelios Therapeutics, Inc.

patents

4. 2 out of 2

Centric Research Institute

patents

5. 2 out of 2

Exodos Life Sciences LP

patents

6. 2 out of 2

Nuvo Pharmaceuticals Inc.

patents

7. 2 out of 52

Teikoku Pharma USA, Inc.

Years Active: 2000-2022

Loading Chart...

Areas of Expertise:

Topical Anti-Inflammatory

Foamable Formulation

Transdermal Delivery

Hormonal Compositions

Prostaglandin Treatments

Erectile Dysfunction

Female Sexual Dysfunction

Highly Permeating Formulation

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11229617 - Topical anti-inflammatory compositions (2022-01-25),

2. 10716754 - Topical formulation (2020-07-21),

3. 10646441 - Foamable formulation (2020-05-12),

4. 10588873 - Topical antifungal compositions (2020-03-17),

5. 10272054 - Topical antifungal compositions (2019-04-30),

6. 9861579 - Foamable formulation (2018-01-09),

7. 9833488 - Sensitization composition and method of use (2017-12-05),

8. 9821021 - Sensitization composition and method of use (2017-11-21),

9. 9579296 - Compositions and methods for transdermal delivery of hormones and other medicinal agents (2017-02-28),

10. 9144553 - Compositions and methods for transdermal delivery of hormones and other medicinal agents (2015-09-29),

11. 9107823 - Foamable formulation (2015-08-18),

12. 9084754 - Highly permeating terbinafine formulation (2015-07-21),

13. 8822537 - Topical ketoprofen composition (2014-09-02),

14. 8470886 - Topical ibuprofen formulations (2013-06-25),

15. 6693135 - Prostaglandin compositions and methods of treatment for male erectile dysfunction (2004-02-17),

Title: Nadir Buyuktimkin: Innovator in Topical Anti-Inflammatory Compositions

Introduction

Nadir Buyuktimkin, based in San Diego, CA, is a notable inventor recognized for his significant contributions to the field of topical pharmaceutical formulations. With an impressive portfolio of 20 patents, his work emphasizes improving therapeutic applications and patient outcomes.

Latest Patents

Nadir's latest patents include advancements in topical anti-inflammatory compositions and formulations aimed at enhancing drug delivery. One key patent involves a composition featuring a non-steroidal anti-inflammatory drug (NSAID) in an innovative aqueous carrier system that incorporates cationic galactomannan gum. This carrier system enhances the effectiveness of the NSAID by including essential components such as lactate ester, a monoprotic arylalkanoic acid, a solubility enhancer, and saturated aliphatic alcohols.

In another notable patent, he has developed a topical formulation comprising pregabalin, water, DMSO, and a keto acid, along with various fatty alcohols and esters. His research indicates that the combination of DMSO with keto acids and fatty components improves skin penetration, facilitating more effective administration of pregabalin.

Career Highlights

Throughout his career, Nadir has made his mark in the pharmaceutical industry, working with respected companies such as Nexmed Holdings Incorporated and Nuvo Research Inc. His innovative mindset and dedication to research have led to valuable contributions that address critical healthcare needs.

Collaborations

Nadir's work has often involved collaboration with esteemed colleagues, including Servet Buyuktimkin and James L. Yeager. Together, they have explored various aspects of drug delivery and formulation science, driving forward advancements in topical applications.

Conclusion

Nadir Buyuktimkin exemplifies the spirit of innovation in pharmaceutical sciences. With his robust patent portfolio and collaborative efforts, he continues to pave the way for new developments that enhance therapeutic options and improve patient care. His contributions will undeniably influence the landscape of topical formulations for years to come.

Profile summary based on public USPTO records.